Skip to main content
oAv Menu
Home
Patient Care Center
Clinical Trials
Providers
Therapeutics
People
Places
Community Center
Community Stories
Social Media
Community Content
Financial Assistance
News
Community Events
Clinical Trials and Research
Business
News People
Happenings
Spotlight
Fundraising Events
Trusted Resources
Education
Videos & Visuals
Event Calendar
Login
Search
CS Blogs
Home
Community Center
Community Stories
CS Blogs
Sep 30, 2024
National Organization for Rare Disorders (NORD) Announces $85,000 in Grant Funding for Amyloidosis and Levy-Yeboa Syndrome
Read more
Sep 30, 2024
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy
Alnylam Pharmaceuticals, Inc. News− Echocardiographic and Cardiac Biomarker Data From the HELIOS-B Study Presented Today Support the Potential of Vutrisiran in…
Read more
Sep 30, 2024
Noninvasive eye test can help diagnose hATTR at early stage
Read more
Sep 30, 2024
National Organization for Rare Disorders (NORD) Announces $85,000 in Grant Funding for Amyloidosis and Levy-Yeboa Syndrome
Read more
Sep 29, 2024
Serum Amyloid P Component as a Therapeutic Target in Amyloidosis
Read more
Sep 24, 2024
ALXN2220 for ATTR amyloidosis with cardiomyopathy granted fast track designation
Read more
Sep 20, 2024
Light-chain amyloidosis with dysphagia as the main symptom: a case report
Read more
Sep 19, 2024
Thirteen-Year Follow-Up of Conjunctival Amyloidosis
Read more
Sep 18, 2024
FDA grants 510(k) clearance to amyloid imaging tool
Read more
Sep 16, 2024
Uncovering the knowledge about systemic amyloidosis relevant to the rheumatologists
Read more
Pagination
1
2
››
Next page
Last »
Last page
Subscribe to
